What is Fresh2 Group Limited (FRES)?

Fresh2 Group Limited (FRES) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of FRES?

The current price of FRES is $0.85. Prices are updated in real time on Stocks360.

What is FRES's price-to-earnings (PE) ratio?

FRES's trailing twelve-month PE ratio is -0.00, based on current price and earnings per share data available on Stocks360.

What is FRES's market capitalization?

FRES's market capitalization is $2,084,999.00, placing it in the small-cap tier.

Fresh2 Group Limited (FRES)

Stock analysis · NASDAQ · Healthcare · Biotechnology

$0.85

Market Cap

$2.08M

PE (TTM)

-0.00

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

1.28

Day Range

$0.73 – $1.42

52-wk Range

$0.73 – $9.00

Avg Volume

N/A

Volume

201.88K

Fresh2 Group Limited (FRES) is a publicly traded company in the Healthcare sector. Latest price: $0.85. Market cap $2.08M. Trailing PE -0.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Dec 29, 2021

EPS $-319.69 vs est. $-20.00

Missed by $299.69

Proprietary Signals

Signal snapshot temporarily unavailable.

About Fresh2 Group Limited

Fresh2 Group Limited, a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science Co., Ltd. The company is primarily engaged in the research, development, promotion, and sale of advanced multi-cancer screening and detection tests within the People's Republic of China, leveraging its proprietary cancer differentiation analysis (CDA) technology and associated devices for corporate and life insurance clients. Beyond these core diagnostic offerings, Fresh2 Group provides comprehensive physical checkup packages and an array of technology services, including market research, design, software coding, development, and testing. The company also markets genetic testing kits and various skincare products. It owns several fundamental technology platforms and actively participates in further technological innovation and product distribution. Adding a unique dimension to its operations, Fresh2 Group also manages an e-commerce platform that facilitates connections between food suppliers and both supermarket operators and restaurant owners.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.00×
P/S (TTM)	1.15×
P/B	-0.00×
P/FCF (TTM)	-0.25×
EV / EBITDA	-0.24×
EV / Sales	2.02×
Earnings Yield	-1881100.87%
Free Cash Flow Yield	-407.64%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$24.34M
Revenue (TTM)	$12.04M
Net Income (TTM)	-$261.43B
Free Cash Flow (TTM)	-$54.93M
Net Debt	$10.44M
Working Capital	-$28.58M
Gross Margin	69.21%
Operating Margin	-870.20%
Net Margin	-846.01%
Return on Equity	1121.57%
Return on Invested Capital	-2573.82%